|
|
|
|
| | | | USD | EUR | GBP | JPY | 83.52 | 88.89 | 103.80 | 0.54 |
| | | | AED | AUD | CHF | CAD | 17.54 | 49.53 | 64.49 | 50.06 |
| | | | HKD | SAR | SGD | ZAR | 8.28 | 17.22 | 47.46 | 4.57 |
|
|
|
|
|
|
|
|
|
|
|
Industry :
|
Pharmaceuticals & Drugs
|
|
|
|
|
|
|
|
|
|
52-Week-High (Rs.)
|
1031.30
|
|
|
|
|
|
|
* BSE PRICES
|
|
|
|
|
|
( Rs. in Million)
|
Particulars | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Profit Before Tax | 20,322.00 | 11,639.00 | 16,885.00 | 16,259.00 | 17,965.00 | Adjustment | 4,751.00 | 7,611.00 | 6,114.00 | 1,007.00 | -517.00 | Changes In working Capital | -10,359.00 | -3,828.00 | 1,911.00 | -3,448.00 | -8,520.00 | Cash Flow after changes in Working Capital | 14,714.00 | 15,422.00 | 24,910.00 | 13,818.00 | 8,928.00 | Cash Flow from Operating Activities | 10,782.00 | 12,722.00 | 22,272.00 | 11,806.00 | 5,807.00 | Cash Flow from Investing Activities | -19,597.00 | 5,862.00 | -27,138.00 | 550.00 | -7,452.00 | Cash Flow from Financing Activities | 8,270.00 | -17,098.00 | 2,553.00 | -9,667.00 | 649.00 | Net Cash Inflow / Outflow | -545.00 | 1,486.00 | -2,313.00 | 2,689.00 | -996.00 | Opening Cash & Cash Equivalents | 3,026.00 | 1,540.00 | 3,853.00 | 1,168.00 | 1,838.00 | Cash & Cash Equivalent on Amalgamation / Take over / Merger | 0 | 0 | 0 | 0 | 326.00 | Cash & Cash Equivalent of Subsidiaries under liquidations | 0 | 0 | 0 | 0 | 0 | Translation adjustment on reserves / op cash balalces frgn subsidiaries | 0 | 0 | 0 | 0 | 0 | Effect of Foreign Exchange Fluctuations | 0 | 0 | 0 | -4.00 | 0 | Closing Cash & Cash Equivalent | 2,481.00 | 3,026.00 | 1,540.00 | 3,853.00 | 1,168.00 |
|
|
|
|
|
|